Resultados de la búsqueda 431-440 of 18926 for Two-phase

  1. Otorrinolaringología (oído, nariz y garganta) y cirugía de cabeza y cuello - Ensayos clínicos - Mayo Clinic

    ... two previously validated quality-of-life scales. ... (Stage I and Stage II). Additinoally, to evaluate ... (Stage I and Stage II). Additinoally, to ...

  2. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  5. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  6. Oncología (médica) - Ensayos clínicos

    ... phase 2 dose (RP2D) 1.1.2 To evaluate the safety ... BiCaZO: A Study Combining Two Immunotherapies ... (Stage I and Stage II). Additinoally, to ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial studies the best dose and side ... [1, 2] The solid tumor stroma acts as an ... This Phase 3 study is designed to evaluate the ...

  9. Ensayos clínicos - Neurología

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

  10. Oncología (médica) - Ensayos clínicos

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...